| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NI1210-1069 |
| P698 | PubMed publication ID | 21079627 |
| P50 | author | John Clemens | Q58987399 |
| Stefan Kaufmann | Q2336447 | ||
| Jan Holmgren | Q5811529 | ||
| Alberto Mantovani | Q22069468 | ||
| P2860 | cites work | Rotavirus: realising the potential of a promising vaccine | Q61700314 |
| The Global Alliance for Vaccines and Immunization--a millennial challenge | Q73956011 | ||
| Effect of the Global Alliance for Vaccines and Immunisation on diphtheria, tetanus, and pertussis vaccine coverage: an independent assessment | Q80335010 | ||
| GAVI enters its second decade with massive funding gap | Q83166606 | ||
| Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. | Q33892877 | ||
| Epidemic meningitis, meningococcaemia, and Neisseria meningitidis | Q34644525 | ||
| Changing funding patterns in tuberculosis | Q36753319 | ||
| An assessment of interactions between global health initiatives and country health systems | Q37525469 | ||
| Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial | Q38879736 | ||
| A cluster-randomized effectiveness trial of Vi typhoid vaccine in India. | Q39961128 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunization | Q1415366 |
| P304 | page(s) | 1069-1072 | |
| P577 | publication date | 2010-12-01 | |
| P1433 | published in | Nature Immunology | Q1071725 |
| P1476 | title | Ten years of the Global Alliance for Vaccines and Immunization: challenges and progress | |
| P478 | volume | 11 |
| Q82479986 | Assessment of the burden of influenza in children |
| Q36973269 | Community vaccine perceptions and its role on vaccination uptake among children aged 12-23 months in the Ileje District, Tanzania: a cross section study |
| Q48967167 | Did the Millennium Development Goals Change Trends in Child Mortality? |
| Q28598117 | Evaluation of medicine retail outlets for sale of typhoid fever vaccine among adults in two urban and rural settings in western Kenya: a proof-of-concept study |
| Q39064227 | Lack of broad functional differences in immunity in fully vaccinated vs. unvaccinated children |
| Q50109364 | Mandatory vaccination in Italy: Time for engagement of immunologists |
| Q50317454 | Measles Vaccination Supports Millennium Development Goal 4: Increasing Coverage and Increasing Child Survival in Northern Ghana, 1996–2012. |
| Q52579157 | Neonatal Immunization: Rationale, Current State, and Future Prospects. |
| Q34439339 | Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges |
| Q36330182 | Overview of global, regional, and national routine vaccination coverage trends and growth patterns from 1980 to 2009: implications for vaccine-preventable disease eradication and elimination initiatives |
| Q36183321 | Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates |
| Q36835607 | Rational design of thermostable vaccines by engineered peptide-induced virus self-biomineralization under physiological conditions |
| Q41433615 | Robust vaccine formulation produced by assembling a hybrid coating of polyethyleneimine-silica. |
| Q64108324 | Structural Vaccinology for Viral Vaccine Design |
| Q26862121 | Systems vaccinology: a promise for the young and the poor |
| Q39740370 | The future of immunisation policy, implementation, and financing |
| Q84336194 | The vaccine paradox |
| Q38167718 | Unmet needs in respiratory diseases : "You can't know where you are going until you know where you have been"--Anonymous |
| Q37041021 | Vaccine-induced immunity in early life |
| Q60307189 | Vaccines: An achievement of civilization, a human right, our health insurance for the future |
| Q36733384 | Variation between Populations in the Innate Immune Response to Vaccine Adjuvants |
Search more.